Times Square Capital Management, LLC Reata Pharmaceuticals Inc Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$79.22 - $105.37 $27 Million - $36 Million	341,180 Added 10034.71%	344,580 $35.1 Million
Q1 2023 May 10, 2023	BUY	$30.85 - $93.17 $104,890 - $316,778	3,400 New	3,400 $309,000
Q3 2020 Nov 06, 2020	SELL	$93.53 - $163.34 $33.3 Million - $58.1 Million	-355,900 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$126.3 - $176.56 $18.3 Million - $25.6 Million	145,000 Added 68.75%	355,900 $55.5 Million
Q1 2020 May 08, 2020	BUY	$124.16 - $247.74 $26.2 Million - $52.2 Million	210,900 New	210,900 $30.4 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.